Cancer-fighting vaccine prompts immune response for some patients
These types of cancer frequently reoccur, even after patients have undergone surgery and chemotherapy. The risk is higher when trace amounts of cancer remain in the body, enabling tumours to grow once again.
To attack these malicious cells, scientists have been experimenting with cancer 'vaccines,' a type of immunotherapy that prompts certain immune cells to recognise and kill cancer cells.
Pancreatic and bowel cancers often occur when people have mutations in the KRAS gene, which helps cancer tumours grow. Researchers say that makes them an ideal target for cancer vaccines.
The new findings, published in the journal Nature Medicine, still need to be validated in larger studies. But they indicate immune-boosting treatments could be promising for certain cancer patients.
The early-stage trial included just 25 people – 20 with pancreatic cancer and five with bowel cancer – who had completed standard treatments but still had signs of cancer in their blood.
While other experimental cancer vaccines are personalised based on patients' specific tumour proteins, the jab used in this study was manufactured in bulk.
After an average of nearly 20 months, 17 of the patients who received the vaccine had developed a strong immune response to the mutant tumour proteins.
The pancreatic cancer patients lived an average of 29 months after vaccination, including more than 15 months cancer-free.
Patients with the strongest immune responses also lived longer and remained cancer-free for longer than those with weaker responses.
The study authors said that while there are other treatment options to target mutant KRAS proteins, the 'off-the-shelf' vaccine could help train patients' immune systems to recognise and attack these cancer cells.
Dr Magnus Dillon, a clinician scientist at the Institute of Cancer Research in the United Kingdom who was not involved with the study, called the results 'extremely promising'.
'Many patients have these KRAS mutations, so an off-the-shelf vaccine could benefit lots of people – it saves the cost and time required to make a personalised vaccine,' Dillon said in a statement.
However, Dillon and other independent experts emphasised that the findings will need to be validated in larger studies before researchers understand how effective they could be.
'While the results are promising and hypothesis-generating, they remain preliminary and will need to be validated in larger, randomised studies before clinical benefit can be confirmed,' Dr Khurum Khan, an oncologist in London, said in a statement.
Richard Sullivan, director of the Institute of Cancer Policy at King's College London, also cautioned that the early findings could be skewed because the study looked at both pancreatic and bowel cancers, 'two widely different cancers with very different prognosis'.
'We've been here before with this sort of approach and not have it translate into tangible efficacy,' Sullivan said in a statement.
The jab is now being tested in a phase 2 randomised trial.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Euronews
5 days ago
- Euronews
Cancer-fighting vaccine prompts immune response for some patients
A so-called cancer vaccine helped prolong the lives of some patients with pancreatic and bowel cancer, an early study has found. These types of cancer frequently reoccur, even after patients have undergone surgery and chemotherapy. The risk is higher when trace amounts of cancer remain in the body, enabling tumours to grow once again. To attack these malicious cells, scientists have been experimenting with cancer 'vaccines,' a type of immunotherapy that prompts certain immune cells to recognise and kill cancer cells. Pancreatic and bowel cancers often occur when people have mutations in the KRAS gene, which helps cancer tumours grow. Researchers say that makes them an ideal target for cancer vaccines. The new findings, published in the journal Nature Medicine, still need to be validated in larger studies. But they indicate immune-boosting treatments could be promising for certain cancer patients. The early-stage trial included just 25 people – 20 with pancreatic cancer and five with bowel cancer – who had completed standard treatments but still had signs of cancer in their blood. While other experimental cancer vaccines are personalised based on patients' specific tumour proteins, the jab used in this study was manufactured in bulk. After an average of nearly 20 months, 17 of the patients who received the vaccine had developed a strong immune response to the mutant tumour proteins. The pancreatic cancer patients lived an average of 29 months after vaccination, including more than 15 months cancer-free. Patients with the strongest immune responses also lived longer and remained cancer-free for longer than those with weaker responses. The study authors said that while there are other treatment options to target mutant KRAS proteins, the 'off-the-shelf' vaccine could help train patients' immune systems to recognise and attack these cancer cells. Dr Magnus Dillon, a clinician scientist at the Institute of Cancer Research in the United Kingdom who was not involved with the study, called the results 'extremely promising'. 'Many patients have these KRAS mutations, so an off-the-shelf vaccine could benefit lots of people – it saves the cost and time required to make a personalised vaccine,' Dillon said in a statement. However, Dillon and other independent experts emphasised that the findings will need to be validated in larger studies before researchers understand how effective they could be. 'While the results are promising and hypothesis-generating, they remain preliminary and will need to be validated in larger, randomised studies before clinical benefit can be confirmed,' Dr Khurum Khan, an oncologist in London, said in a statement. Richard Sullivan, director of the Institute of Cancer Policy at King's College London, also cautioned that the early findings could be skewed because the study looked at both pancreatic and bowel cancers, 'two widely different cancers with very different prognosis'. 'We've been here before with this sort of approach and not have it translate into tangible efficacy,' Sullivan said in a statement. The jab is now being tested in a phase 2 randomised trial.
France 24
01-08-2025
- France 24
What are all these microplastics doing to our brains?
These mostly invisible pieces of plastic have been found everywhere from the top of mountains to the bottom of oceans, in the air we breathe and the food we eat. They have also been discovered riddled throughout human bodies, inside lungs, hearts, placentas and even crossing the blood-brain barrier. The increasing ubiquity of microplastics has become a key issue in efforts to hammer out the world's first plastic pollution treaty, with the latest round of UN talks being held in Geneva next week. The effects that microplastics and even smaller nanoplastics have on human health is not yet fully understood, but researchers have been working to find out more in this relatively new field. The most prominent study looking at microplastics in brains was published in the journal Nature Medicine in February. The scientists tested brain tissue from 28 people who died in 2016 and 24 who died last year in the US state of New Mexico, finding that the amount of microplastics in the samples increased over time. The study made headlines around the world when the lead researcher, US toxicologist Matthew Campen, told the media that they detected the equivalent of a plastic spoon's worth of microplastics in the brains. Campen also told Nature that he estimated the researchers could isolate around 10 grammes of plastic from a donated human brain -- comparing that amount to an unused crayon. Speculation 'far beyond the evidence' But other researchers have since urged caution about the small study. "While this is an interesting finding, it should be interpreted cautiously pending independent verification," toxicologist Theodore Henry of Scotland's Heriot-Watt University told AFP. "Currently, the speculation about the potential effects of plastic particles on health go far beyond the evidence," he added. Oliver Jones, a chemistry professor at Australia's RMIT University, told AFP there was "not enough data to make firm conclusions on the occurrence of microplastics in New Mexico, let alone globally". He also found it "rather unlikely" that brains could contain more microplastics than has been found in raw sewage -- as the researchers had estimated. Jones pointed out the people in the study were perfectly healthy before they died, and that the researchers acknowledged there was not enough data to show that the microplastics caused harm. "If (and it is a big if in my view) there are microplastics in our brains, there is as yet no evidence of harm," Jones added. The study also contained duplicated images, the neuroscience news website The Transmitter has reported, though experts said this did not affect its main findings. - 'Cannot wait for complete data' - Most of the research into the effects microplastics have on health has been observational, which means it cannot establish cause and effect. One such study, published in the New England Journal of Medicine last year, found that microplastics building up in blood vessels was linked to an increased risk of heart attack, stroke and death in patients with a disease that clogs arteries. There have also been experiments carried out on mice, including a study in Science Advances in January which detected microplastics in their brains. The Chinese researchers said that microplastics can cause rare blood clots in the brains of mice by obstructing cells -- while emphasising that the small mammals are very different to humans. A review by the World Health Organization in 2022 found that the "evidence is insufficient to determine risks to human health" from microplastics. However many health experts have cited the precautionary principle, saying the potential threat microplastics could pose requires action. A report on the health risks of microplastics by the Barcelona Institute for Global Health published this week ahead of the treaty talks said that "policy decisions cannot wait for complete data". "By acting now to limit exposure, improve risk assessment methodologies, and prioritise vulnerable populations, we can address this pressing issue before it escalates into a broader public health crisis," it added. The amount of plastic the world produces has doubled since 2000 -- and is expected to triple from current rates by 2060.
Sustainability Times
10-07-2025
- Sustainability Times
'Plastic Is Invading Your Brain!': Explosive Global Study Links Shocking Microplastic Levels Directly to Skyrocketing Dementia and Memory Collapse
IN A NUTSHELL 🧠 Microplastics are now found in human brain tissue, raising new health concerns beyond environmental issues. are now found in human brain tissue, raising new health concerns beyond environmental issues. 🔍 The study reveals that microplastics are 12 times more concentrated in the brain than in other organs, with potential links to dementia. in the brain than in other organs, with potential links to dementia. 🌍 The significant increase in microplastic concentration in brain tissue over the past eight years is tied to the global rise in plastic production. ⚠️ Scientists emphasize the urgent need for research into how microplastics may impact brain function and contribute to neurological diseases. Recent revelations from the University of New Mexico have unveiled a disturbing reality: microplastics are not only infiltrating our environment but are now accumulating in the human brain. This new study underscores the urgent need to address plastic pollution as a significant health concern, especially considering the potential link to neurodegenerative diseases like dementia. As microplastics become more pervasive in our daily lives, from our clothing to our food, the implications for human health are becoming increasingly alarming. Understanding the extent of this contamination is crucial for devising strategies to mitigate its impact on public health. Unprecedented Findings: Microplastics in the Brain The study published in Nature Medicine marks a groundbreaking discovery in the field of plastic pollution research. While microplastics have been previously detected in various parts of the body, this is the first time significant concentrations have been documented in the brain. Researchers found that microplastics are 12 times more concentrated in brain tissue compared to organs like the liver and kidneys. This discovery is particularly concerning because the brain is the command center of the human body, and any foreign substance has the potential to disrupt its critical functions. Most of the particles identified were polyethylene, commonly found in plastic bottles and packaging. The study revealed that individuals with dementia had up to ten times the amount of microplastics in their brains compared to healthy individuals. This correlation raises serious questions about the potential role of these particles in exacerbating or even initiating neurological disorders. The implications of such findings could reshape our understanding of dementia and its causes. 'Crystal Turns Violet on Contact': Scientists Reveal Pyrazinacene's Shocking Ability to Detect Pollution Instantly and Visibly The Mechanics of Microplastic Accumulation Microplastics, defined as particles smaller than 5 millimeters, possess the ability to breach the body's most protective barriers, including the blood-brain barrier. This capability allows them to infiltrate and accumulate in brain tissue, specifically in the myelin sheath, which insulates nerve cells. This accumulation could potentially hinder neural communication and exacerbate conditions like dementia. Given their diminutive size, ranging from visible fragments to particles as tiny as 200 nanometers, microplastics easily permeate the body's defenses. The myelin sheath's role in facilitating efficient nerve signaling makes it a critical area of concern for scientists. Understanding how these particles impact this essential component of the nervous system is paramount for assessing the broader health implications of microplastic exposure. 'US Scientists Sound the Alarm': These Microscopic Nanoplastics Are Now Proven to Absorb Toxic Heavy Metal Ions at Alarming Rates A Surge in Microplastic Concentration The study highlights a staggering increase in microplastic levels in brain tissue over the past eight years. Samples collected in 2024 showed a median concentration of 4,917 micrograms of plastic per gram of brain tissue, equivalent to four to five paper clips worth of plastic per pound of brain tissue. This sharp rise is attributed to the global surge in plastic production and environmental contamination. Food and water are significant sources of exposure, with contaminated water, plastic-laden animal feed, and fertilizers contributing to the accumulation of microplastics in the food chain. This widespread exposure underscores the need for immediate action to curb plastic production and explore alternatives to single-use plastics. As microplastics continue to permeate our environment, their impact on human health is becoming increasingly difficult to ignore. 'Scientists Issue Red Alert': Disturbing Discovery in Remote Indian Ocean Reveals Hidden Crisis Spanning the Entire Marine Ecosystem Microplastics and Dementia: A Growing Concern The study's findings raise alarm bells about the potential link between microplastics and dementia. Individuals with dementia exhibited significantly higher concentrations of microplastics around blood vessels and immune cell clusters in their brains. This observation suggests that microplastics might contribute to the aggregation of proteins, a hallmark of neurodegenerative diseases. Lead researcher Matthew Campen emphasizes the urgency of understanding how microplastics might disrupt neural connections or obstruct blood flow, potentially exacerbating cognitive decline. While more research is needed to establish a direct link between microplastics and dementia, the study provides a crucial foundation for future investigations. The potential health risks associated with microplastic exposure demand immediate attention and action. Health Risks Beyond the Brain While the brain has been the focal point of this study, the potential impact of microplastics on other organs cannot be overlooked. The accumulation of plastic particles in the liver, kidneys, and lungs raises broader health concerns. As the most complex organ in the body, the brain's vulnerability highlights the potential risks microplastics pose to overall human health. Even if plastic production were to cease immediately, existing microplastics would continue to degrade and persist in the environment for decades. This ongoing contamination necessitates urgent interventions to mitigate the health crisis posed by microplastic exposure. The study serves as a wake-up call for governments, industries, and individuals to address the plastic epidemic before it spirals further out of control. This pivotal research serves as a stark reminder of the urgent need to tackle plastic pollution, not just as an environmental issue but as a growing public health crisis. The revelation of microplastics in the human brain marks a turning point in our understanding of their potential impact on neurological health. As we grapple with the pervasiveness of plastic in our lives, the question remains: What steps will we take to protect future generations from the mounting threat of microplastic contamination? This article is based on verified sources and supported by editorial technologies. Did you like it? 4.3/5 (23)
